MELD（终末期肝病模型）评分

预约门诊
打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究

除了发明准确诊断肝硬化的技术外，妙佑医疗国际研究人员还开发了终末期肝病（MELD）评分模型。目前，MELD 评分系统已在全美范围内使用，用于评估患者的疾病进展和分配移植器官。

移植研究中心的研究人员正积极致力于研究改进的外科类手术、开发新型抗排斥药物、治疗方法和技术，以提高移植安全性并惠及更多患者。妙佑医疗国际的科学家、医生和外科医生深入了解肝移植并探索创新方法，使移植更安全，惠及更多患者。他们积极参与肝移植相关各方面医疗状况的实验室研究、临床试验及其他研究。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在 MELD 评分领域的著述目录。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
Jan. 13, 2026
打印
  1. Guo G, et al. The development and appraisal of MELD 3.0 in liver diseases: Good things never come easy. Journal of Clinical Translational Hepatology. 2024; doi:10.14218/JCTH.2020.00303.
  2. Kim WR, et al. MELD 3.0: The model for end-stage liver disease updated for the modern era. Gastroenterology. 2021; doi:10.1053/j.gastro.2021.08.050.
  3. A guide to taking warfarin. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/a-patients-guide-to-taking-warfarin. Accessed July 25, 2025.
  4. Wang Y, et al. Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis. Frontiers. 2021; doi:10.3389/fmed.2021.762291.
  5. Creatinine. National Kidney Foundation. https://www.kidney.org/kidney-topics/creatinine. Accessed July 28, 2025.
  6. Casciola R, et al. Creatine supplementation to improve sarcopenia in chronic liver disease: Facts and perspectives. Nutrients. 2023; doi:10.3390/nu15040863.
  7. Guerra Ruiz AR, et al. Measurement and clinical usefulness of bilirubin in liver disease. Advances in Laboratory Medicine. 2021; doi:10.1515/almed-2021-0047.
  8. Lenci I, et at. Natremia and liver transplantation: The right amount of salt for a good recipe. World Journal of Hepatology. 2020; doi:10.4254/wjh.v12.i11.919.
  9. Edema (swelling) and cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/side-effects/edema. Accessed July 28, 2025.
  10. Nouraie M, et al. Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts. PLOS One. 2020; doi:10.1371/journal.pone.0237543.
  11. Dale E, et al. Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States. BMC Medical Ethics. 2024; doi:10.1186/s12910-024-011.
  12. Becchetti C, et al. Sex-based disparities in liver transplantation: Evidence from a nationwide Italian cohort. JHEP Reports. 2025; doi:10.1016/j.jhepr.2025.101387.
  13. Bambha K, et al. Model for end-stage liver disease (MELD). https://www.uptodate.com/contents/search. Accessed Aug. 7, 2025.
  14. Bednar R, et al. Low back pain in patients hospitalised with liver cirrhosis — A retrospective study. BMC Musculoskeletal Disorders. 2023; doi:10.1186/s12891-023-06424-8.
  15. Forna L, et al. Pediatric perspectives on liver cirrhosis: Unravelling clinical patterns and therapeutic challenges. Journal of Clinical Medicine. 2024; doi:10.3390/jcm13144275.
  16. Yun G, et al. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean Journal of Internal Medicine. 2022; doi:10.3904/kjim.2022.346.
  17. Gines P, et al. Liver cirrhosis. The Lancet. 2021; doi:10.1016/S0140-6736(21)01374-X.
  18. Alcohol-associated liver disease. American Liver Foundation. https://liverfoundation.org/liver-diseases/alcohol-associated-liver-disease/#1507302760988-870375fd-f7al. Accessed Aug. 7, 2025.
  19. Questions and answers about liver allocation. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/patients/by-organ/liver/questions-and-answers-about-liver-allocation. Accessed Aug. 7, 2025.
  20. Puri P, et al. Liver transplantation: Contraindication and ineligibility. Journal of Clinical and Experimental Hepatology. 2023; doi:10.1016/j.jceh.2023.04.005.
  21. Luo Z, et al. MELD as a metric for survival benefit of liver transplantation. American Journal of Transplantation. 2018; doi:10.1111/ajt.14660.
  22. Ge J, et al. "Beyond MELD" — Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. Journal of Hepatology. 2022; doi:10.1016/j.jhep.2022.03.003.
  23. Ni K, et al. MELD score reflects the mood, sleep, and daily living ability in liver transplantation candidates: A descriptive study. Annals of Transplantation. 2020; doi:10.12659/AOT.926857.
  24. Kiene SM, et al. Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: Study protocol for the Ekkubo/PATH cluster randomized controlled trial. BMC Infectious Diseases. 2017; doi:10.1186/s12879-017-2537-z.
  25. Bendersky VA, et al. The evolving role of liver transplantation for metastatic colorectal cancer: current perspectives and future directions. Frontiers in Surgery. 2025; doi:10.3389/fsurg.2025.1608467.
  26. Cameron JL, et al. Liver transplantation. In: Current Surgical Therapy. 14th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 19, 2025.
  27. Goldstein NE, et al. What are the causes and complications of chronic liver disease and what is the evidence for palliative care delivery to those affected by it? In: Evidence-Based Practice of Palliative Medicine. 2nd ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 20, 2025.
  28. MELD calculator. Mayo Clinic. https://www.mayoclinic.org/medical-professionals/transplant-medicine/calculators/meld-model/itt-20434705. Accessed Aug. 20, 2025.
  29. MELD score and 90-day mortality rate for alcoholic hepatitis. Mayo Clinic. https://www.mayoclinic.org/medical-professionals/transplant-medicine/calculators/meld-score-and-90-day-mortality-rate-for-alcoholic-hepatitis/itt-20434719. Accessed Aug. 20, 2025.
  30. Learn about MELD. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/allocation-calculators/meld-calculator/learn-about-meld. Accessed Aug. 20, 2025.
  31. MELD scores and mortality. Merck Manual Professional Version. https://www.merckmanuals.com/professional/multimedia/table/meld-scores-and-mortality. Accessed Aug. 20, 2025.
  32. Liver transplant. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/liver-transplant/about/pac-20384842. Accessed Sept. 25, 2025.
  33. Cirrhosis. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cirrhosis/symptoms-causes/syc-20351487. Accessed Sept. 25, 2025.

相关

Mayo Clinic 新闻

MELD（终末期肝病模型）评分